OPK - Opko Health Inc

https://www.opko.com

Buy Momentum: Bearish

Recent News

OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands

Zacks Commentary • 1 month, 1 week ago • score: -0.16

OPKO Health reports wider-than-expected second-quarter 2025 loss and revenue decline, but gross margin expands and product sales remain stable.

Neutral

OPKO Health ( OPK ) Reports Q2 Loss, Lags Revenue Estimates

Zacks Commentary • 1 month, 2 weeks ago • score: 0.01

OPKO Health (OPK) delivered earnings and revenue surprises of -58.33% and -5.09%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

OPKO Health, Inc., a healthcare company, is engaged in the pharmaceutical and diagnostic businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company is headquartered in Miami, Florida.

52W High

$2.04

52W Low

$1.11

MA Status:

50D: Above 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.40

Valuation

Rich

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

64.52

EV/EBITDA (<8 favorable)

20.05

EV/Revenue (<3 favorable)

1.80

P/S (TTM) (<3 favorable)

1.61

P/B (<3 favorable)

0.83

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

46.77%

Institutions (25–75% balanced)

26.32%

Shares Outstanding

793,783,000

Float

376,547,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

664,029,000

Gross Profit (TTM)

96,434,000

EPS (TTM)

-0.26

Profit Margin (>10% good)

-0.27%

Operating Margin (TTM) (higher better)

-0.38%

ROE (TTM) (>15% strong)

-0.13%

EPS YoY (Quarterly) (>10% good)

0.19

Revenue YoY (Quarterly) (>8% good)

-0.14

Momentum

Bearish momentum

Value

0.0204

0.0219

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025